Gastroenteropancreatic neuroendocrine tumour arising in Meckel’s diverticulum coexisting with colon adenocarcinoma

Uložené v:
Podrobná bibliografia
Názov: Gastroenteropancreatic neuroendocrine tumour arising in Meckel’s diverticulum coexisting with colon adenocarcinoma
Autori: Katalinić, Darko, Šantek, Fedor, Juretić, Antonio, Škegro, Dinko, Pleština, Stjepko
Zdroj: World J Surg Oncol
Informácie o vydavateľovi: Springer Science and Business Media LLC, 2014.
Rok vydania: 2014
Predmety: Gastroenteropancreatic neuroendocrine tumour, Male, Meckel Diverticulum/surgery, Colon adenocarcinoma, Meckel's diverticulum, Intestinal Neoplasms/surgery, Meckel Diverticulum/pathology, Adenocarcinoma/surgery, Case Report, Neoplasms, Multiple Primary/surgery, Stomach Neoplasms/secondary, Adenocarcinoma, Intestinal Neoplasms/secondary, Pancreatic Neoplasms/secondary, Neoplasms, Multiple Primary, 03 medical and health sciences, 0302 clinical medicine, Stomach Neoplasms, Adenocarcinoma/secondary, Pancreatic Neoplasms/surgery, Intestinal Neoplasms, Neuroendocrine Tumors/secondary, Humans, Neoplasms, Multiple Primary/pathology, Neuroendocrine Tumors/surgery, Neoplasm Staging, Colonic Neoplasms/pathology, Colonic Neoplasms/surgery, Middle Aged, Prognosis, 3. Good health, Meckel Diverticulum, Pancreatic Neoplasms, Stomach Neoplasms/surgery, Neuroendocrine Tumors, Oncology, Colonic Neoplasms, Surgery
Popis: Although colon cancer is the third most common cause of cancer-related death worldwide, the prevalence of gastroenteropancreatic neuroendocrine tumours (GEP-NETs) remains rare. To date, very few cases of GEP-NETs within Meckel's diverticulum and synchronous colorectal cancer have been reported. Although the coexistence of these two tumour types is uncommon, it is important to be aware of their disease patterns. We present a rare case of a patient with an intestinal GEP-NET arising in Meckel's diverticulum coexisting with metastatic colon adenocarcinoma, and we discuss the clinical manifestations and the diagnostic procedures and treatment modalities used. This case report underlines the importance of being aware of this particular coexistence, as well as the unlikely metastatic spread of GEP-NETs and the importance of a multidisciplinary approach to cancer treatment. Finally, individualizing the treatment according to the stages of the primaries will result in durable cancer control, particularly in synchronous double malignancy.
Druh dokumentu: Article
Other literature type
Popis súboru: application/pdf
Jazyk: English
ISSN: 1477-7819
DOI: 10.1186/1477-7819-12-358
Prístupová URL adresa: https://wjso.biomedcentral.com/track/pdf/10.1186/1477-7819-12-358
https://pubmed.ncbi.nlm.nih.gov/25427657
https://www.ncbi.nlm.nih.gov/pubmed/25427657
https://link.springer.com/content/pdf/10.1186%2F1477-7819-12-358.pdf
https://wjso.biomedcentral.com/articles/10.1186/1477-7819-12-358
https://link.springer.com/article/10.1186/1477-7819-12-358/fulltext.html
http://europepmc.org/articles/PMC4258279
https://link.springer.com/article/10.1186/1477-7819-12-358
http://doi.org/10.1186/1477-7819-12-358
Rights: CC BY
URL: http://rightsstatements.org/vocab/InC/1.0/
Prístupové číslo: edsair.doi.dedup.....73b8374a0e7f9817da1fc9bca050ee9c
Databáza: OpenAIRE
Popis
Abstrakt:Although colon cancer is the third most common cause of cancer-related death worldwide, the prevalence of gastroenteropancreatic neuroendocrine tumours (GEP-NETs) remains rare. To date, very few cases of GEP-NETs within Meckel's diverticulum and synchronous colorectal cancer have been reported. Although the coexistence of these two tumour types is uncommon, it is important to be aware of their disease patterns. We present a rare case of a patient with an intestinal GEP-NET arising in Meckel's diverticulum coexisting with metastatic colon adenocarcinoma, and we discuss the clinical manifestations and the diagnostic procedures and treatment modalities used. This case report underlines the importance of being aware of this particular coexistence, as well as the unlikely metastatic spread of GEP-NETs and the importance of a multidisciplinary approach to cancer treatment. Finally, individualizing the treatment according to the stages of the primaries will result in durable cancer control, particularly in synchronous double malignancy.
ISSN:14777819
DOI:10.1186/1477-7819-12-358